Said S, Müller J M
Department of Surgery, University of Berlin, Charité.
Swiss Surg. 1997;3(6):248-54.
The aim of this study is to outline the use of transanal endoscopic microsurgery (TEM) for local excision of rectal carcinoma. Thus the clinical and long-term results regarding endorectal excision of the rectal lesions at the University Hospital of Cologne and Berlin will be presented. During the period July 1983 till December 1993 the system has been employed on 405 cases (17.8% carcinomas) at the University Hospital of Cologne and on 60 cases (20% carcinomas) during the period September 1994 till September 1996 at the University Hospital of Berlin, Charité. Early postoperative complications consisted of intraperitoneal perforations (five cases); rectovaginal fistulas (four cases); haemorrhages (four cases), death due to cardiopulmonary failure (two cases). All the complications occurred within the first 4 years of the learning phase. The cancer-specific 3-year survival rate of patients with "low risk" pT1 cancers amounted to 91%. Two recurrences after local excision of pT1 cancers occurred 1 year postoperatively, which were treated successfully using the TEM system. Most of the histologic findings of the subsequent radical operations following local resections of infiltrative rectal cancers revealed that the carcinoma had already been totally removed. The main indication for TEM is the removal of sessile adenomas. Early rectal carcinomas (pT1) of the "low risk" type, with favourable histological grading (grade 1 and 2) and clinical staging (CS I) were also considered for endorectal therapeutical approach. Even though our initial results do show encouraging results, regarding endorectal excision of pT2 cancers, more experience is needed to clarify the indication for locally amenable pT2 cancers of the "low risk" type and rule out the role of adjuvant therapy after complete excision of these carcinomas. The indication for TEM encloses also confined (< 4 cm) infiltrative cancers (> pT1) in cases where the patient is unwilling to undergo extensive surgery or due to medical reasons. The technique allows accurate endoscopic microsurgical excision of early cancers for cure with minimal morbidity and excellent presentation of specimen for complete histological analysis. Diligent follow-up is mandatory, since most (60-80%) of local recurrences can be treated successfully. Thus demolitive surgery can be avoided in selected cases with rectal cancer.
本研究的目的是概述经肛门内镜显微手术(TEM)在直肠癌局部切除中的应用。因此,将展示科隆大学医院和柏林大学医院关于直肠病变经直肠内切除的临床及长期结果。在1983年7月至1993年12月期间,科隆大学医院对405例患者(其中17.8%为癌)应用了该系统;在1994年9月至1996年9月期间,柏林夏里特大学医院对60例患者(其中20%为癌)应用了该系统。术后早期并发症包括腹腔内穿孔(5例);直肠阴道瘘(4例);出血(4例),因心肺衰竭死亡(2例)。所有并发症均发生在学习阶段的前4年内。“低风险”pT1期癌症患者的癌症特异性3年生存率为91%。pT1期癌症局部切除术后1年出现2例复发,采用TEM系统成功治疗。浸润性直肠癌局部切除术后后续根治性手术的大多数组织学检查结果显示,癌已被完全切除。TEM的主要适应证是切除无蒂腺瘤。“低风险”型早期直肠癌(pT1),具有良好的组织学分级(1级和2级)和临床分期(CS I),也可考虑采用经直肠内治疗方法。尽管我们的初步结果确实令人鼓舞,但对于pT2期癌症的经直肠内切除,仍需要更多经验来明确“低风险”型局部可切除pT2期癌症的适应证,并排除这些癌症完全切除后辅助治疗的作用。TEM的适应证还包括在患者不愿接受广泛手术或因医学原因的情况下,局限于(<4 cm)浸润性癌症(>pT1)。该技术能够通过内镜精确显微切除早期癌症以实现治愈,发病率极低,且能出色地呈现标本以供完整的组织学分析。必须进行严格的随访,因为大多数(60 - 80%)局部复发可以成功治疗。因此在部分直肠癌病例中可以避免进行破坏性手术。